共 50 条
- [1] Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents[J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6Li, Chun-JunLiu, Xiao-JuanBai, LianYu, QianZhang, Qiu-MeiYu, PeiYu, De-Min
- [2] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent[J]. Diabetology & Metabolic Syndrome, 7Yun-Zhao TangGang WangZhen-Huan JiangTian-Tian YanYi-Jun ChenMin YangLing-Ling MengYan-Juan ZhuChen-Guang LiZhu LiPing YuChang-Lin Ni
- [3] Efficacy and Safety of Vildagliptin, Sitagliptin, and Linagliptin as Add-on Therapy in Chinese Patients with T2DM Inadequately Controlled with Dual Combination of Insulin and Traditional Oral Hypoglycemic Agent[J]. DIABETES, 2016, 65 : A302 - A302Ni, Chang-LinTang, Yun-ZhaoWang, GangJiang, Zhen-HuanYan, Tian-TianYang, MinChen, Yi-JunMeng, Ling-LingZhu, Yan-JuanLi, Chen-GuangLi, ZhuYu, Ping
- [4] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent[J]. DIABETOLOGY & METABOLIC SYNDROME, 2015, 7Tang, Yun-ZhaoWang, GangJiang, Zhen-HuanYan, Tian-TianChen, Yi-JunYang, MinMeng, Ling-LingZhu, Yan-JuanLi, Chen-GuangLi, ZhuYu, PingNi, Chang-Lin
- [5] Efficacy and Safety Comparison of Add-on Therapy with Liraglutide, Saxagliptin and Vildagliptin, All in Combination with Current Conventional Oral Hypoglycemic Agents Therapy in Poorly Controlled Chinese Type 2 Diabetes[J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (08) : 469 - 476Li, C. -J.Yu, Q.Yu, P.Zhang, Q. -M.Ding, M.Liu, X. -J.Yu, D. -M.
- [6] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy[J]. DIABETES CARE, 2014, 37 (07) : 1924 - 1930Fouqueray, PascalePirags, ValdisDiamant, MichaelaSchernthaner, GuntramLebovitz, Harold E.Inzucchi, Silvio E.Bailey, Clifford J.
- [7] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136Jin, S. -M.Park, S. W.Yoon, K. -H.Lee, M. -K.
- [8] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin[J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430Rosenstock, JulioMathieu, ChantalChen, HungtaGarcia-Sanchez, RicardoSaraiva, Gabriela Luporini
- [9] Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial[J]. DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2408 - 2415Han, Kyung-AhChon, SukChung, Choon HeeLim, SooLee, Kwan-WooBaik, SeiHyunJung, Chang HeeKim, Dong-SunPark, Kyong SooYoon, Kun-HoLee, In-KyuCha, Bong-SooSakatani, TaishiPark, SumiLee, Moon-Kyu
- [10] Safety and efficacy of linagliptin as add-on therapy to a sulphonylurea in inadequately controlled type 2 diabetes[J]. DIABETOLOGIA, 2010, 53Lewin, A. J.Arvay, L.Liu, D.Patel, S.Woerle, H. -J.